Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
1,604 GBX | -0.08% |
|
-2.16% | +10.64% |
Jun. 12 | Moderna's RSV Vaccine Has 'Ample Opportunity' Despite Seasoned Competitors, Oppenheimer Says | MT |
Jun. 12 | GSK: licensing agreement with Ochre Bio | CF |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registration![Consensus](/images/consensus_flch.gif)
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
+10.64% | 84.04B | |
+48.79% | 781B | |
+41.60% | 639B | |
+19.43% | 330B | |
+7.18% | 293B | |
+17.26% | 248B | |
-0.12% | 221B | |
+11.39% | 217B | |
+4.53% | 162B | |
-3.92% | 157B |
- Stock Market
- Equities
- GSK Stock
- News GSK plc
- BELLUS Health Inc. Calls Special Shareholders' Meeting in Connection with GSK Acquisition